| Financial Year |
March 31 2023 |
| Monetary Funds |
31,272,316,250.52 |
| Held-for-trading Financial Assets |
1,498,309,326.90 |
| Notes Receivable |
974,157,506.70 |
| Accounts Receivable |
19,160,874,004.89 |
| Advances to Suppliers |
587,453,384.75 |
| Other Receivables |
447,602,866.52 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
29,546,235,823.62 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,808,998,395.35 |
| Total Current Assets |
85,295,947,559.25 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,349,883,976.77 |
| Investment Properties |
86,352,498.55 |
| Fixed Assetes |
43,567,469,438.72 |
| Under-construction Projects |
3,186,584,926.65 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,655,162,914.85 |
| R&D expenses |
-- |
| Goodwill |
1,730,047,190.39 |
| Long-Term Deferred and Prepaid Expenses |
622,383,166.82 |
| Deferred Income Tax Assets |
1,145,324,889.68 |
| Other Non-Current Assets |
2,702,373,667.53 |
| Sub-Total of Non-Current Assets |
61,161,418,915.84 |
| Total Assets |
146,457,366,475.09 |
| Short-Term Loans |
23,386,107,454.72 |
| Trading Financial liabilities |
52,422,175.87 |
| Notes Payable |
438,222,754.62 |
| Accounts Payable |
34,726,842,067.15 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,140,159,039.79 |
| Taxes Payable |
557,123,385.29 |
| Interest Payable |
-- |
| Dividend Payable |
12,564,174.42 |
| Other payables |
352,895,204.53 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
821,135,316.01 |
| Other Current Liabilities |
2,929,678,165.50 |
| Sub-Total of Current Liabilities |
64,625,900,787.75 |
| Long-term Loans |
15,323,817,186.58 |
| Bonds Payable |
2,719,761,200.71 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
689,096.80 |
| Deferred Income Tax Liabilities |
1,449,096,828.66 |
| Other Non-Current Liabilities |
240,561.79 |
| Sub-Total of Non-Current Liabilities |
20,896,779,405.86 |
| Total Liabilities |
85,522,680,193.61 |
| Paid-In Capital(Or Share Stock) |
7,124,470,493.00 |
| Capital Surplus |
3,881,334,990.15 |
| Surplus Reserve |
1,121,072,698.83 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
34,306,347,912.78 |
| Minority Stockholder's Interest |
13,518,727,708.96 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
47,415,958,572.52 |
| Owner's Equity（Stockholder's Equity） |
60,934,686,281.48 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
146,457,366,475.09 |
